Results 71 to 80 of about 26,721 (231)

IV or Nebulized Tranexamic Acid for Hemoptysis [PDF]

, 2023
Nicolas Cazes, Anaïs Briquet, B. Delcasso   +2 more
openalex   +1 more source

Post‑Marketing Surveillance of the Safety and Effectiveness of Emicizumab in Japanese Patients With Congenital Haemophilia A With Inhibitors

Haemophilia, EarlyView.
ABSTRACT Introduction The bispecific monoclonal antibody emicizumab was approved for prophylactic treatment of congenital haemophilia A (HA) in Japan in 2018. Aim To monitor long‐term safety and effectiveness of emicizumab, including appropriate concomitant use of bypassing agents (BPAs), in Japanese patients with congenital HA with inhibitors who ...
Midori Shima, Katsuyuki Fukutake, Masanori Matsumoto, Yoshihiko Sugimura, Chiaki Sugita, Lyu Ji, Mika Kawano, Tadashi Matsushita   +7 more
wiley   +1 more source

Effect and safety of topical application of tranexamic acid to reduce perioperative blood loss in elderly patients with intertrochanteric fracture undergoing PFNA [PDF]

, 2020
Huiping Wei, Tianji Huang, Jianfeng He, Menghong Xia   +3 more
openalex   +1 more source

Needle of Death Thromboelastography Tracings in Severely Bleeding Trauma Patients: A Novel Predictor of Hemorrhagic Blood Failure and Futile Resuscitation?

Academic Emergency Medicine, EarlyView.
Connor M. Bunch, Mark M. Walsh, Ernest E. Moore, Hunter B. Moore, Peter K. Moore, Jeffrey L. Johnson, Samuel J. Thomas, Sarah S. Fox, Daniel F. Lewandowski, Joseph B. Miller   +9 more
wiley   +1 more source

Integration of Efanesoctocog Alfa in Clinical Practice for Children, Adolescents, and Young Adults With Severe Haemophilia A

Haemophilia, EarlyView.
ABSTRACT Introduction Efanesoctocog alfa is a novel, “ultra‐extended half‐life” FVIII concentrate for bleed treatment and prevention in haemophilia A. Clinical trials excluded individuals with active or prior FVIII inhibitors, those on emicizumab, and previously untreated patients (PUPs).
Debbie Jiang, Natalie Johnston, Daniel Echelman, Stacy E. Croteau   +3 more
wiley   +1 more source

Tranexamic Acid Diminishes Laser-Induced Melanogenesis [PDF]

, 2015
Myoung Shin Kim, Seunghyun Bang, Jeong‐Hwan Kim, Hong Ju Shin, Jee Ho Choi, Sung Eun Chang   +5 more
openalex   +1 more source

Assessment of Tranexamic Acid in Reducing Intraoperative Blood Loss During Rhytidectomy [PDF]

, 2021
Kristen A. Echanique, Rhorie Kerr, Irene Kim, Gregory S. Keller, Vishad Nabili   +4 more
openalex   +1 more source

International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD)

Haemophilia, EarlyView.
ABSTRACT Background Glanzmann thrombasthenia (GT) is an inherited platelet disorder resulting in severely reduced platelet aggregation and increased bleeding tendency. Pregnancy and childbirth in women with GT present significant challenges for both mother and child.
Karlijn H. G. Rutten, Roger E. G. Schutgens, Roseline d'Oiron, Mathieu Fiore, Giancarlo Castaman, Keith Gomez, Mary Mathias, Michelle Lavin, Petra Elfvinge, Rezan Abdul Kadir, Karin P. M. van Galen, the Glanzmann Thrombasthenia and Women and Girls with Bleeding Disorders Working Groups of the EAHAD   +11 more
wiley   +1 more source

Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial

Stroke and Vascular Neurology
Background Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in intracerebral ...
Liping Liu, Yuehua Pu, Yongjun Wang, Yan Wang, Xingquan Zhao, Hongqiu Gu, Qi Zhou, Yibin Cao, Wenzhi Wang, Dacheng Liu, Jingyi Liu, Haixin Sun, Zhonghua Yang, Ximing Nie, Miao Wen, Shengjun Sun, Ying Tan, Lina Zheng, Jiahui Zhao, Haomeng Zhu, Yunpeng Zhang, Lijin Yi   +21 more
doaj   +1 more source

To Study the Effect of Prophylactic use of Tranexamic Acid in Postpartum Blood Loss after Normal Vaginal Delivery

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2023
Background: Postpartum hemorrhage is responsible for major morbidity and mortality all over the world. Uterotonics are used to prevent uterine atony and decrease blood loss after delivery.
Sushil Chawla, Nilopher Siddique, Tony Jose   +2 more
doaj